Head Of Early Assets, Hematology

AstraZeneca

Gaithersburg, MD, USA
Base: $270,221 - $405,332; bonus/equity: not speci...
Commercial strategy for hematology assets
Experience in early asset strategy
Strong matrix leadership skills
AstraZeneca aims to transform outcomes for patients with hematologic malignancies

Job Summary

  • AstraZeneca aims to transform outcomes for patients with hematologic malignancies.
  • The Head of Early Assets will shape the early hematology pipeline from preclinical through early clinical development.
  • This role requires a strong matrix leader who can translate scientific innovation into commercial strategies.

Matching Summary

AstraZeneca aims to transform outcomes for patients with hematologic malignancies.

Salary

Base: $270,221 - $405,332; Bonus/Equity: Not specified; Benefits: Health benefits, retirement program, paid vacation

Skills & Requirements

Must-have

  • Commercial strategy for hematology assets
  • Experience in early asset strategy
  • Strong matrix leadership skills

Nice-to-have

  • Ability to influence without authority
  • Excellent written and verbal communication
  • Strong grasp of hematology disease biology

Key Requirements

  • MD required; hematology-trained physician preferred
  • 10+ years in biopharma with hematology experience
  • Experience engaging external stakeholders

Work Rights

Not specified

Tailored Resume

Cover Letter